Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-027238
Filing Date
2019-12-31
Accepted
2019-12-31 10:03:33
Documents
4
Period of Report
2019-12-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k123019a_portagebiotech.htm 6-K 10585
2 CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED JUNE 30, 20 f6k123019aex99-1_portage.htm EX-99.1 294238
3 MANAGEMENT'S DISCUSSION AND ANALYSIS FOR THE THREE MONTHS ENDED JUNE 30, 2019. P f6k123019aex99-2_portage.htm EX-99.2 124745
4 GRAPHIC image_001.jpg GRAPHIC 93337
  Complete submission text file 0001213900-19-027238.txt   559453
Mailing Address 47 AVENUE ROAD SUITE 200 TORONTO A6 M5R 2G3
Business Address 47 AVENUE ROAD SUITE 200 TORONTO A6 M5R 2G3 416-929-1806
PORTAGE BIOTECH INC. (Filer) CIK: 0001095435 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 000-30314 | Film No.: 191318295
SIC: 1311 Crude Petroleum & Natural Gas